TrialInternational journal of clinical practice2022

Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial.

David Staskin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.